Download FREE Practo app
Get ₹200 HealthCash
Primary myelofibrosis with JAK 2 mutatio
My farther aged 67 has been identified with prim myelofibrosis, he was advised to take Jakafi but that dropped his blood levels and didnt suit the body. he is now taking thalomid but has been detected with thyroid as well. he has not been eating ever since the tablets have begun due to which he has been hospitalized often for drips and is drowsy.
Not finding what you need? Ask Practo AI
FREE
Chat with Practo AI on Whatsapp
Didn't find the answer you are looking for?
Talk to experienced oncologist online and get your health questions answered in just 5 minutes.
Hi
There are very limited treatment options for Primary myelofibrosis apart from Jakafi.Even with Jakafi tolerance remains a major concern. Therapy responses to thalidomide and lenalidomide remain limited. In case JAKAFI is not tolerated there are options for dose modification, hope all options explored before stopping JAKAFI. At this present clinical status as per your description, we need to have a realistic approach to treatment decisions, with a goal to limit symptoms and discomfort ...sorry I could not contribute more..
Best wishes
Dr Rakesh Pinninti
Answered
Let others know if this answer was helpful
Not finding what you need? Ask Practo AI
FREE
Chat with Practo AI on Whatsapp
Articles you may like
Tell us what's troubling you
Disclaimer : The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.